Identifying Tumor Antigens in Liver Cancer
Author Information
Author(s): Shi Y-Y, Wang H-C, Yin Y-H, Sun W-S, Li Y, Zhang C-Q, Wang Y, Wang S, Chen W-F
Primary Institution: Peking University Health Science Center
Hypothesis
To identify tumour and tumour-associated antigens in patients with hepatocellular carcinoma (HCC) to find potential diagnostic markers and immunotherapeutic targets.
Conclusion
The study identified 30 distinct antigens associated with HCC, with CAGE and transgelin 2 showing potential as diagnostic markers and immunotherapeutic targets.
Supporting Evidence
- CAGE mRNA was expressed in 39.4% of HCC patients.
- Transgelin 2 was overexpressed in 69% of HCC specimens.
- Antibodies against CAGE protein were detected in approximately 5.1% of HCC patients.
Takeaway
Researchers found special proteins in liver cancer that could help doctors diagnose and treat the disease better.
Methodology
The study used serological analysis of cDNA expression libraries (SEREX) and cDNA microarray to identify and analyze tumor-associated antigens.
Potential Biases
Potential bias in antigen identification due to the selection of specific patient samples.
Limitations
The study may not account for all potential antigens due to the limited sample size and specific patient demographics.
Participant Demographics
Patients with hepatocellular carcinoma from Peking University teaching hospitals and Sun Yat-Sen University.
Statistical Information
P-Value
p≤0.05
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website